95826-4SARS-CoV-2 (COVID-19) RNA panel - Saliva (oral fluid) by NAA with probe detectionActive
Term Description
This panel contains results for the detection of Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), initially known as 2019-Novel Coronavirus (2019-nCoV), in a saliva specimen using nucleic acid amplification assays with probe-based detection for the diagnosis of Coronavirus Disease 2019 (COVID-19).
Source: Regenstrief LOINC
Part Descriptions
LP417539-6 SARS coronavirus 2 RNA panel
The Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), first known as 2019 Novel Coronavirus (2019-nCoV), was first identified as the cause of a respiratory illness outbreak, later defined as Coronavirus Disease 2019 (COVID-19), in Wuhan, China. The full genome of the SARS-CoV-2 that causes COVID-19 was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Real time Reverse Transcription-Polymerase Chain Reaction (rRT-PCR) tests targeting regions within genes, including RdRp, S, N, M, and E genes, specific to SARS-CoV-2 have been developed by the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO) and others for the diagnosis of COVID-19. Some assays only detect SARS-CoV-2 and other assays detect other strains (e.g. SARS-CoV) that are genetically similar.[CDC:coronavirus/2019-ncov][https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance]
Source: Regenstrief LOINC
LP7565-7 Saliva
Saliva is produced primarily by the parotid, submaxillary, and sublingual glands. It is secreted at the rate of 0-3 milliliters per minute which is affected by various factors including anxiety, hydration and hunger. Oral fluid is broadly used to test for drugs of abuse in employment and forensic settings, and is especially useful since it is difficult to adulterate, is quick and is non-invasive. Oral fluid is used to test a variety of analytes, including to test alcohol, HIV and other antibodies, therapeutic drugs and steroids, but its primary use is to test for drugs of abuse including amphetamines, cocaine and metabolites, opioids, methadone, cannabis and heroin.[PMID:17268583]
Source: Regenstrief LOINC
Panel Hierarchy
Details for each LOINC in Panel
LHC-Forms
| LOINC | Name | R/O/C | Cardinality | Example UCUM Units |
|---|---|---|---|---|
| 95826-4 | SARS-CoV-2 (COVID-19) RNA panel - Saliva (oral fluid) by NAA with probe detection | |||
| Indent95425-5 | SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by NAA with probe detection | |||
| Indent96448-6 | SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by Nucleic acid amplification using CDC primer-probe set N1 | |||
| Indent96958-4 | SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by Nucleic acid amplification using CDC primer-probe set N2 | |||
| Indent95824-9 | SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Saliva (oral fluid) by NAA with probe detection | |||
| Indent96091-4 | SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Saliva (oral fluid) by NAA with probe detection | |||
| Indent96765-3 | SARS-CoV-2 (COVID-19) S gene [Presence] in Saliva (oral fluid) by NAA with probe detection | |||
| Indent94845-5 | SARS-CoV-2 (COVID-19) RNA [Presence] in Saliva (oral fluid) by NAA with probe detection | |||
| Indent95823-1 | SARS-related coronavirus E gene [Presence] in Saliva (oral fluid) by NAA with probe detection |
Fully-Specified Name
- Component
- SARS coronavirus 2 RNA panel
- Property
- -
- Time
- Pt
- System
- Saliva
- Scale
- -
- Method
- Probe.amp.tar
Additional Names
- Short Name
- SARS-CoV-2 RNA Pnl Sal NAA+probe
- Display Name
- SARS-CoV-2 (COVID-19) RNA panel NAA+probe (Sal)
- Consumer Name Alpha
- SARS-CoV-2 (COVID-19) RNA Panel, Saliva
Basic Attributes
- Class
- PANEL.MICRO
- Type
- Laboratory
- First Released
- Version 2.69
- Last Updated
- Version 2.70
- Order vs. Observation
- Order
- Panel Type
- Panel
Reference Information
| Type | Source | Reference |
|---|---|---|
| Webcontent | Lab Tests Online®Copyright Copyright © 2021 Lab Tests Online. All rights reserved. | Coronavirus (COVID-19) Testing |
Member of these Groups
| LG51017-8 | SARSCoV2 detection |
| LG51019-4 | SARSCoV2 molecular detection |
Language Variants Get Info
- zh-CNChinese (China)
- SARS 冠状病毒 2 RNA 组套:
-: 时间点: 唾液: -: 探针法.基因扩增.靶向 - nl-NLDutch (Netherlands)
- SARS-CoV-2 RNA panel:
-: moment: speeksel: -: moleculaire techniek (PCR) - fr-CAFrench (Canada)
- Coronavirus 2 du SRAS, ARN:
-: Temps ponctuel: Salivaire: -: Sonde avec amplification de la cible - fr-FRFrench (France)
- Coronavirus SARS-CoV-2 ARN panel:
-: Ponctuel: Salive: -: PCR amplification de cible - de-DEGerman (Germany)
- SARS-Coronavirus 2 RNA (Liste):
-: Zeitpunkt: Speichel: -: Zielfragmentamplifikation mit Sondendetektion - it-ITItalian (Italy)
- SARS coronavirus 2, panel RNA:
-: Pt: Saliva: -: Sonda.amp.tar - es-MXSpanish (Mexico)
- Panel de ARN del coronavirus 2 del SARS:
-: Punto temporal: Saliva: -: Amplificación de ácidos nucleicos con detección de sonda - es-ESSpanish (Spain)
- Panel de ARN del SARS-CoV-2 (COVID-19):
Propiedades mixtas (sólo paneles): Punto temporal: Saliva: -: Sonda con amplificación dirigida
LOINC FHIR® API Example - CodeSystem and Questionnaire Requests Get Info
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=95826-4
https://fhir.loinc.org/Questionnaire/?url=http://loinc.org/q/95826-4
LOINC Copyright
Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright